01:30 PM EDT, 05/14/2025 (MT Newswires) -- Health care stocks declined Wednesday afternoon with both the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) dropping 1.9%.

The iShares Biotechnology ETF (IBB) retreated 1.8%.

In corporate news, GSK (GSK) agreed to acquire Boston Pharmaceuticals' steatotic liver disease therapeutic candidate for up to $2 billion in cash as the UK drugmaker looks to expand its hepatology portfolio. GSK shares eased 0.1%.